{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T22:24:48Z","timestamp":1779315888874,"version":"3.51.4"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2020,5,27]],"date-time":"2020-05-27T00:00:00Z","timestamp":1590537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,27]],"date-time":"2020-05-27T00:00:00Z","timestamp":1590537600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s10067-020-05153-w","type":"journal-article","created":{"date-parts":[[2020,5,27]],"date-time":"2020-05-27T00:02:36Z","timestamp":1590537756000},"page":"3747-3755","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Relationship between post-IVIG IgG levels and clinical outcomes in Kawasaki disease patients: new insight into the mechanism of action of IVIG"],"prefix":"10.1007","volume":"39","author":[{"given":"Ryunosuke","family":"Goto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Inuzuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Shindo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiyuki","family":"Namai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoichiro","family":"Oda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Harita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Oka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,5,27]]},"reference":[{"issue":"8411","key":"5153_CR1","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/s0140-6736(84)91504-6","volume":"2","author":"K Furusho","year":"1984","unstructured":"Furusho K, Kamiya T, Nakano H, Kiyosawa N, Shinomiya K, Hayashidera T, Tamura T, Hirose O, Manabe Y, Yokoyama T (1984) High-dose intravenous gammaglobulin for Kawasaki disease. Lancet 2(8411):1055\u20131058. https:\/\/doi.org\/10.1016\/s0140-6736(84)91504-6","journal-title":"Lancet"},{"issue":"17","key":"5153_CR2","doi-asserted-by":"publisher","first-page":"e927","DOI":"10.1161\/CIR.0000000000000484","volume":"135","author":"BW McCrindle","year":"2017","unstructured":"McCrindle BW, Rowley AH, Newburger JW, Burns JC, Bolger AF, Gewitz M, Baker AL, Jackson MA, Takahashi M, Shah PB, Kobayashi T, Wu MH, Saji TT, Pahl E, American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; Council on Cardiovascular Surgery and Anesthesia; and Council on Epidemiology and Prevention (2017) Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation 135(17):e927\u2013e999. https:\/\/doi.org\/10.1161\/CIR.0000000000000484","journal-title":"Circulation"},{"issue":"3","key":"5153_CR3","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1111\/ped.12762","volume":"58","author":"Y Nakagama","year":"2016","unstructured":"Nakagama Y, Inuzuka R, Hayashi T, Shindo T, Hirata Y, Shimizu N, Inatomi J, Yokoyama Y, Namai Y, Oda Y, Takamizawa M, Harita Y, Oka A (2016) Fever pattern and C-reactive protein predict response to rescue therapy in Kawasaki disease. Pediatr Int 58(3):180\u2013184. https:\/\/doi.org\/10.1111\/ped.12762","journal-title":"Pediatr Int"},{"issue":"3","key":"5153_CR4","doi-asserted-by":"publisher","first-page":"191","DOI":"10.2165\/11538910-000000000-00000","volume":"31","author":"S Iwashima","year":"2011","unstructured":"Iwashima S, Kimura M, Ishikawa T, Ohzeki T (2011) Importance of C-reactive protein level in predicting non-response to additional intravenous immunoglobulin treatment in children with Kawasaki disease: a retrospective study. Clin Drug Investig 31(3):191\u2013199. https:\/\/doi.org\/10.2165\/11538910-000000000-00000","journal-title":"Clin Drug Investig"},{"issue":"2","key":"5153_CR5","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.jpeds.2013.01.022","volume":"163","author":"T Kobayashi","year":"2013","unstructured":"Kobayashi T, Kobayashi T, Morikawa A, Ikeda K, Seki M, Shimoyama S, Ishii Y, Suzuki T, Nakajima K, Sakamoto N, Arakawa H (2013) Efficacy of intravenous immunoglobulin combined with prednisolone following resistance to initial intravenous immunoglobulin treatment of acute Kawasaki disease. J Pediatr 163(2):521\u2013526. https:\/\/doi.org\/10.1016\/j.jpeds.2013.01.022","journal-title":"J Pediatr"},{"key":"5153_CR6","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1136\/adc.2007.126144","volume":"93","author":"T Furukawa","year":"2008","unstructured":"Furukawa T, Kishiro M, Akimoto K, Nagata S, Shimizu T, Yamashiro Y (2008) Effects of steroid pulse therapy on immunoglobulin-resistant Kawasaki disease. Arch Dis Child 93:142\u2013146. https:\/\/doi.org\/10.1136\/adc.2007.126144","journal-title":"Arch Dis Child"},{"issue":"10","key":"5153_CR7","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1097\/INF.0b013e318220c3cf","volume":"30","author":"H Suzuki","year":"2011","unstructured":"Suzuki H, Terai M, Hamada H, Honda T, Suenaga T, Takeuchi T, Yoshikawa N, Shibuta S, Miyawaki M, Oishi K, Yamaga H, Aoyagi H, Iwahashi S, Miyashita R, Onouchi Y, Sasago K, Suzuki Y, Hata A (2011) Cyclosporin A treatment for Kawasaki disease refractory to initial and additional intravenous immunoglobulin. Pediatr Infect Dis J 30(10):871\u2013876. https:\/\/doi.org\/10.1097\/INF.0b013e318220c3cf","journal-title":"Pediatr Infect Dis J"},{"key":"5153_CR8","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.jpeds.2008.06.011","volume":"153","author":"JC Burns","year":"2008","unstructured":"Burns JC, Best BM, Mejias A, Mahony L, Fixler DE, Jafri HS, Melish ME, Jackson MA, Asmar BI, Lang DJ, Connor JD, Capparelli EV, Keen ML, Mamun K, Keenan GF, Ramilo O (2008) Infliximab treatment of intravenous immunoglobulin-resistant Kawasaki disease. J Pediatr 153:833\u2013838. https:\/\/doi.org\/10.1016\/j.jpeds.2008.06.011","journal-title":"J Pediatr"},{"key":"5153_CR9","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.1161\/CIRCULATIONAHA.105.592865","volume":"113","author":"T Kobayashi","year":"2006","unstructured":"Kobayashi T, Inoue Y, Takeuchi K, Okada Y, Tamura K, Tomomasa T, Kobayashi T, Morikawa A (2006) Prediction of intravenous immunoglobulin non-response in patients with Kawasaki disease. Circulation 113:2606\u20132612. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.105.592865","journal-title":"Circulation"},{"key":"5153_CR10","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.jpeds.2006.03.050","volume":"149","author":"K Egami","year":"2006","unstructured":"Egami K, Muta H, Ishii M, Suda K, Sugahara Y, Iemura M, Matuishi T (2006) Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease. J Pediatr 149:237\u2013240. https:\/\/doi.org\/10.1016\/j.jpeds.2006.03.050","journal-title":"J Pediatr"},{"key":"5153_CR11","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s00431-006-0223-z","volume":"166","author":"T Sano","year":"2007","unstructured":"Sano T, Kurotobi S, Matsuzaki K, Yamamoto T, Maki I, Miki K, Kogaki S, Hara J (2007) Prediction of non-responsiveness to standard high-dose \u03b3-globulin therapy in patients with acute Kawasaki disease before starting initial treatment. Eur J Pediatr 166:131\u2013137. https:\/\/doi.org\/10.1007\/s00431-006-0223-z","journal-title":"Eur J Pediatr"},{"issue":"3","key":"5153_CR12","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1007\/s10067-018-4339-0","volume":"38","author":"MA Yamazaki-Nakashimada","year":"2019","unstructured":"Yamazaki-Nakashimada MA, G\u00e1mez-Gonz\u00e1lez LB, Murata C, Honda T, Yasukawa K, Hamada H (2019) IgG levels in Kawasaki disease and its association with clinical outcomes. Clin Rheumatol 38(3):749\u2013754. https:\/\/doi.org\/10.1007\/s10067-018-4339-0","journal-title":"Clin Rheumatol"},{"issue":"23","key":"5153_CR13","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1056\/NEJM199106063242305","volume":"324","author":"JW Newburger","year":"1991","unstructured":"Newburger JW, Takahashi M, Beiser AS, Burns JC, Bastian J, Chung KJ, Colan SD, Duffy CE, Fulton DR, Glode MP, Mason WH, Meissner HC, Rowley AH, Shulman ST, Reddy V, Sundel RP, Wiggins JW, Colton T, Melish ME, Rosen FS (1991) A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med 324(23):1633\u20131639. https:\/\/doi.org\/10.1056\/NEJM199106063242305","journal-title":"N Engl J Med"},{"issue":"9826","key":"5153_CR14","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1016\/S0140-6736(11)61930-2","volume":"379","author":"T Kobayashi","year":"2012","unstructured":"Kobayashi T, Saji T, Otani T, Takeuchi K, Nakamura T, Arakawa H, Kato T, Hara T, Hamaoka K, Ogawa S, Miura M, Nomura Y, Fuse S, Ichida F, Seki M, Fukazawa R, Ogawa C, Furuno K, Tokunaga H, Takatsuki S, Hara S, Morikawa A, RAISE study group investigators (2012) Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial. Lancet 379(9826):1613\u201320.1. https:\/\/doi.org\/10.1016\/S0140-6736(11)61930-2","journal-title":"Lancet"},{"issue":"2","key":"5153_CR15","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1111\/j.1442-200x.2005.02033.x","volume":"47","author":"M Ayusawa","year":"2005","unstructured":"Ayusawa M, Sonobe T, Uemura S, Ogawa S, Nakamura Y, Kiyosawa N, Ishii M, Harada K, Kawasaki Disease Research Committee (2005) Revision of diagnostic guidelines for Kawasaki disease (the 5th revised edition). Pediatr Int 47(2):232\u2013234. https:\/\/doi.org\/10.1111\/j.1442-200x.2005.02033.x","journal-title":"Pediatr Int"},{"key":"5153_CR16","doi-asserted-by":"publisher","DOI":"10.1007\/978-0-387-21606-5","volume-title":"The elements of statistical learning","author":"T Hastie","year":"2001","unstructured":"Hastie T, Tibshirani R, Friedman JH (2001) The elements of statistical learning. Springer-Verlag, New York"},{"issue":"1","key":"5153_CR17","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/1756-185X.13220","volume":"21","author":"MS Lo","year":"2018","unstructured":"Lo MS, Newburger JW (2018) Role of intravenous immunoglobulin in the treatment of Kawasaki disease. Int J Rheum Dis 21(1):64\u201369. https:\/\/doi.org\/10.1111\/1756-185X.13220","journal-title":"Int J Rheum Dis"},{"issue":"9","key":"5153_CR18","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1097\/FPC.0b013e328363686e","volume":"23","author":"R Makowsky","year":"2013","unstructured":"Makowsky R, Wiener HW, Ptacek TS, Silva M, Shendre A, Edberg JC, Portman MA, Shrestha S (2013) Fc\u03b3R gene copy number in Kawasaki disease and intravenous immunoglobulin treatment response. Pharmacogenet Genomics 23(9):455\u2013462. https:\/\/doi.org\/10.1097\/FPC.0b013e328363686e","journal-title":"Pharmacogenet Genomics"},{"issue":"4","key":"5153_CR19","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.iac.2008.06.006","volume":"28","author":"FA Bonilla","year":"2008","unstructured":"Bonilla FA (2008) Pharmacokinetics of immunoglobulin administered via intravenous or subcutaneous routes. Immunol Allergy Clin North Am 28(4):803\u2013819. https:\/\/doi.org\/10.1016\/j.iac.2008.06.006","journal-title":"Immunol Allergy Clin North Am"},{"issue":"24","key":"5153_CR20","doi-asserted-by":"publisher","first-page":"7311","DOI":"10.1113\/JP274819","volume":"595","author":"MJ Eigenmann","year":"2017","unstructured":"Eigenmann MJ, Karlsen TV, Krippendorff BF, Tenstad O, Fronton L, Otteneder MB, Wiig H (2017) Interstitial IgG antibody pharmacokinetics assessed by combined in vivo- and physiologically-based pharmacokinetic modelling approaches. J Physiol 595(24):7311\u20137330. https:\/\/doi.org\/10.1113\/JP274819","journal-title":"J Physiol"},{"issue":"4","key":"5153_CR21","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004000","volume":"2003","author":"RM Oates-Whitehead","year":"2003","unstructured":"Oates-Whitehead RM, Baumer JH, Haines L, Love S, Maconochie IK, Gupta A, Roman K, Dua JS, Flynn I (2003) Intravenous immunoglobulin for the treatment of Kawasaki disease in children. Cochrane Database Syst Rev 2003(4):CD004000. https:\/\/doi.org\/10.1002\/14651858.CD004000","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"5153_CR22","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1253\/circj.69.962","volume":"69","author":"R Baba","year":"2005","unstructured":"Baba R, Shibata A, Tsurusawa M (2005) Single high-dose intravenous immunoglobulin therapy for Kawasaki disease increases plasma viscosity. Circ J 69(8):962\u2013964. https:\/\/doi.org\/10.1253\/circj.69.962","journal-title":"Circ J"},{"issue":"3","key":"5153_CR23","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.jpeds.2005.10.027","volume":"148","author":"Y Wada","year":"2006","unstructured":"Wada Y, Kamei A, Fujii Y, Ishikawa K, Chida S (2006) Cerebral infarction after high-dose intravenous immunoglobulin therapy for Kawasaki disease. J Pediatr 148(3):399\u2013400. https:\/\/doi.org\/10.1016\/j.jpeds.2005.10.027","journal-title":"J Pediatr"},{"issue":"11","key":"5153_CR24","doi-asserted-by":"publisher","first-page":"2564","DOI":"10.1111\/trf.14879","volume":"58","author":"BE Nolan","year":"2018","unstructured":"Nolan BE, Wang Y, Pary PP, Luban NLC, Wong ECC, Ronis T (2018) High-dose intravenous immunoglobulin is strongly associated with hemolytic anemia in patients with Kawasaki disease. Transfusion 58(11):2564\u20132571. https:\/\/doi.org\/10.1111\/trf.14879","journal-title":"Transfusion"},{"key":"5153_CR25","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.jpeds.2016.07.035","volume":"178","author":"Y Kawamura","year":"2016","unstructured":"Kawamura Y, Takeshita S, Kanai T, Yoshida Y, Nonoyama S (2016) The combined usefulness of the neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in predicting intravenous immunoglobulin resistance with Kawasaki disease. J Pediatr 178:281\u2013284.e1. https:\/\/doi.org\/10.1016\/j.jpeds.2016.07.035","journal-title":"J Pediatr"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-020-05153-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-020-05153-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-020-05153-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,26]],"date-time":"2021-05-26T23:58:05Z","timestamp":1622073485000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-020-05153-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,27]]},"references-count":25,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["5153"],"URL":"https:\/\/doi.org\/10.1007\/s10067-020-05153-w","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,27]]},"assertion":[{"value":"18 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The study was approved by the Institutional Review Board at the University of Tokyo (IRB number: 10103-(1)).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Passive parental consent (opt-out consent) for the retrospective use of data was obtained for all participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Passive parental consent (opt-out consent) for publication of this study was obtained for all participants.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}